Related Experiment Video
Updated: Jun 17, 2026
09:57
Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Published on: September 20, 2024
What is new in paediatric epilepsy?
Peter Camfield1, Carol Camfield
1Department of Pediatrics, Dalhousie University and the IWK Health Centre, Halifax, Nova Scotia.
Paediatrics & Child Health
|December 19, 2009
Summary
Recent advances improve childhood epilepsy diagnosis and treatment, with new imaging and genetic insights. While long-term remission is predictable and death is rare, adult social outcomes remain a concern.
Area of Science:
- Pediatric Neurology
- Epileptology
- Clinical Neuroscience
Background:
- Epilepsy diagnosis in children traditionally requires two or more unprovoked seizures.
- Advances in neuroimaging and molecular genetics are revealing new causative factors and syndromes.
- Current management strategies include pharmacological and non-pharmacological interventions.
Purpose of the Study:
- To review recent advancements in the understanding and management of childhood epilepsy.
- To highlight the impact of new diagnostic tools and treatment modalities.
- To discuss the predictability of remission and long-term outcomes.
Main Methods:
- Review of epidemiological data for diagnostic criteria.
- Analysis of magnetic resonance imaging findings in identifying brain malformations.
- Exploration of molecular genetics in understanding epilepsy mechanisms.
- Evaluation of clinical studies on treatment efficacy and remission prediction.
Main Results:
- Diagnosis of epilepsy is confirmed by two or more unprovoked seizures.
- Neuroimaging identifies novel causative brain malformations, influencing counseling and treatment.
- Molecular genetics elucidates mechanisms for several epilepsy syndromes.
- Non-medication treatments like ketogenic diet and vagus nerve stimulation are increasingly utilized.
- Long-term remission in children with epilepsy can be predicted with reasonable accuracy.
- Mortality associated with childhood epilepsy is very low.
Conclusions:
- Significant progress has been made in understanding and managing pediatric epilepsy.
- While prognosis for remission and survival is generally good, adult social outcomes require further attention.
- Integration of advanced diagnostics and therapeutics offers improved patient care and counseling.
More Related Videos
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
07:01Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:13Seizures: Classification
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...